Patent Assignment
Reel/Frame 061433/0786
Security Interest
Recorded: 2022-09-14
Pages: 31
Assignor
BIOSPLICE THERAPEUTICS, INC.
Executed: 2022-09-12
Assignees
VICKERS VENTURE FUND VI PTE. LTD.
1 HARBOURFRONT AVENUE, #16-06, KEPPEL BAY TOWER, SINGAPORE, 098632, SINGAPORE
VICKERS VENTURE FUND VI (PLAN) PTE. LTD.
1 HARBOURFRONT AVENUE, #16-06, KEPPEL BAY TOWER, SINGAPORE, 098632, SINGAPORE
VICKERS-SPLICE CO-INVESTMENT LLC
WILLOW HOUSE, CRICKET SQUARE, PO BOX 709, GRAND CAYMAN, KY1-1107, CAYMAN ISLANDS
MED-PATHWAYS II LIMITED
VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN, TORTOLA, VG 1110, VIRGIN ISLANDS, BRITISH
Covered Properties
(139)
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Treatment of Osteoarthritis
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-C]Pyridines and Their Anti-Inflammatory Uses Thereof
Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
1H-Pyrrolo[2,3-B]Pyridines and Preparation and Uses Thereof
Application:
63/254,713 →
4-Alkoxypyrrolo[2,1-F][1,2,4]Triazines and Preparation and Uses Thereof
Application:
63/355,076 →
5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
7H-Pyrrolo[2,3-D]Pyrimidines and Preparation and Uses Thereof
Application:
63/254,708 →
7H-Pyrrolo[2,3-D]Pyrimidines and Preparation and Uses Thereof
Application:
63/330,480 →
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Methods of Treating Cancer Using a Clk Inhibitor
Application:
17/254,352 →
Publication:
US 2022/0062240
Methods of Treating Cartilage Disorders Through Inhibition of Clk and Dyrk
Application:
17/423,761 →
Publication:
US 2023/0000842
Pyrrolo[2,1-F][1,2,4]Triazines and Preparation and Uses Thereof
Application:
63/254,733 →
Pyrrolo[2,1-F][1,2,4]Triazines and Preparation and Uses Thereof
Application:
63/347,757 →
Single-Dose, Ready-to-Use Injectable Formulations
ß- AND Y -DIKETONES AND Y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORS
Application:
17/113,895 →
Publication:
US 2021/0353604
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Beta- and Gamma-Diketones and Gamma-Hydroxyketones as Wnt/Beta-Catenin Signaling Pathway Activators
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors
Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors
Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Treatment of Osteoarthritis
Treatment of Osteoarthritis
3-(1H-Indol-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B] Pyridines and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B] Pyridines and Therapeutic Uses Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-C]Pyridines and Their Anti-Inflammatory Uses Thereof
Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Single-Dose, Ready-to-Use Injectable Formulations
6-(6-Membered Heteroaryl & Aryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Diazanaphthalen-3-Yl Carboxamides and Preparation and Use Thereof
Indazole Containing Macrocycles and Therapeutic Uses Thereof
5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 24, 2010
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: EPITHERIX, LLC
Reel/Frame 024875/0129 →
Assignment of Assignor's Interest
Jun 26, 2012
From: EPITHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 028442/0355 →
Assignment of Assignor's Interest
Jul 6, 2020
From: DESHMUKH, VISHAL; MURPHY, ERIC ANTHONY; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 053124/0625 →
Assignment of Assignor's Interest
Aug 4, 2020
From: DELLAMARY, LUIS A.
To: SAMUMED, LLC
Reel/Frame 053394/0913 →
Assignment of Assignor's Interest
Dec 4, 2020
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR; YAZICI, YUSUF
To: SAMUMED, LLC
Reel/Frame 054542/0569 →
Assignment of Assignor's Interest
Dec 8, 2020
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR; YAZICI, YUSUF
To: SAMUMED, LLC
Reel/Frame 054581/0106 →
Assignment of Assignor's Interest
Dec 8, 2020
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: WINTHERIX LLC
Reel/Frame 054581/0367 →
Change of Name
Dec 8, 2020
From: WINTHERIX LLC
To: SAMUMED, LLC
Reel/Frame 054581/0436 →
Assignment of Assignor's Interest
Dec 21, 2020
From: TAM, BETTY; BOSSARD, CARINE; CHIU, KEVIN TSENG; CHUNG, HEEKYUNG
To: SAMUMED, LLC
Reel/Frame 054710/0341 →
Assignment of Assignor's Interest
Dec 31, 2020
From: KC, SUNIL KUMAR; MAK, CHI CHING; MITTAPALLI, GOPI KUMAR; HOFILENA, BRIAN JOSEPH
To: SAMUMED, LLC
Reel/Frame 054785/0748 →
Assignment of Assignor's Interest
Jan 25, 2021
From: KC, SUNIL KUMAR; MAK, CHI CHING; EASTMAN, BRIAN WALTER; CAO, JIANGUO
To: SAMUMED, LLC
Reel/Frame 055013/0686 →
Assignment of Assignor's Interest
Feb 9, 2021
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 055197/0695 →
Assignment of Assignor's Interest
Feb 23, 2021
From: HOOD, JOHN; WALLACE, DAVID MARK; KUMAR KC, SUNIL
To: SAMUMED, LLC
Reel/Frame 055375/0764 →
Assignment of Assignor's Interest
Mar 23, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 055693/0882 →
Assignment of Assignor's Interest
Mar 23, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 055694/0001 →
Assignment of Assignor's Interest
Mar 24, 2021
From: KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 055699/0974 →
Assignment of Assignor's Interest
Mar 24, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 055700/0010 →
Assignment of Assignor's Interest
May 6, 2021
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 056161/0559 →
Assignment of Assignor's Interest
May 11, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 056220/0557 →
Assignment of Assignor's Interest
Jun 25, 2021
From: HOOD, JOHN; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 056664/0994 →
Assignment of Assignor's Interest
Jun 25, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 056680/0755 →
Assignment of Assignor's Interest
Jul 8, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 056805/0177 →
Assignment of Assignor's Interest
Jul 8, 2021
From: HOOD, JOHN; KC, SUNIL KUMAR; KIBAR, OSMAN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 056794/0933 →
Assignment of Assignor's Interest
Jul 21, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 056928/0695 →
Assignment of Assignor's Interest
Jul 21, 2021
From: HOOD, JOHN; DESHMUKH, VISHAL; O'GREEN, ALYSSA-LAUREN; BOSSARD, CARINE
To: SAMUMED, LLC
Reel/Frame 056928/0435 →